ASCO is pleased to announce the winners of the 2008 election. The President-Elect and members of the Board of Directors and Nominating Committee are dedicated to advancing the ASCO mission and will work to promote policies that effectively serve the needs of a multidisciplinary, international membership.
“It will be my privilege and pleasure to work with the newly elected leadership, in particular, the newly elected President-Elect, Dr. Douglas Blayney,” said Allen S. Lichter, MD, Chief Executive Officer of ASCO. “For over a decade, Dr. Blayney has committed his time and dedication to the Society through various volunteer and leadership positions. ASCO is fortunate to have such a highly qualified oncologist and dedicated ASCO member lead the Society’s efforts to improve cancer care and prevention.”
The newly elected leaders, who come from a variety of specialties and professional situations, described several issues and themes to be addressed during their terms in office. Among these is the need to implement the most recent advances in clinical science while also educating policymakers about the challenges posed by insufficient reimbursement and decreased funding for oncology research; advancing basic, translational, and clinical research through collaborations with public and private entities; working to improve access to clinical trials and support programs designed for cancer survivors; and developing strategies to alleviate the future shortage in the oncology workforce.
“I am honored to have been elected to serve as ASCO President, following in the very large footsteps of those who have served before me,” said Dr. Blayney. “ASCO is an exceptional organization and I look forward to working alongside my esteemed colleagues on the Board of Directors to continue improving the care and treatment of those living with cancer.”
The President-Elect and new members of the Board of Directors and Nominating Committee will be introduced during the Annual Business Meeting, to be held on Monday, June 2, in conjunction with the Annual Meeting. Members are encouraged to attend this event, where they will have the opportunity to meet the newly elected leaders and to witness the passing of the presidential gavel.
2008 ASCO Election Results
President-Elect
Douglas W. Blayney, MD
Dr. Blayney is a professor of internal medicine at the University of Michigan School of Medicine and medical director of the school’s Comprehensive Cancer Center.
Board of Directors
Undesignated Specialty
Bruce E. Johnson, MD
Dr. Johnson is director of the Lowe Center of Thoracic Oncology at the Dana-Farber Cancer Institute and Brigham and Women’s Hospital and a professor of medicine at Harvard Medical School.
Sandra Swain, MD
Dr. Swain is the medical director of the Washington Cancer Institute at Washington Hospital Center.
Board of Directors
Surgical Oncologist
Monica M. Bertagnolli, MD
Dr. Bertagnolli is associate professor of surgery at Harvard Medical School and an associate surgeon at Brigham and Women’s Hospital and the Dana-Farber Cancer Institute.
Board of Directors
Community Oncologist
Robert Langdon, Jr., MD
Dr. Langdon works in private oncology practice and is president of Oncology Hematology West, P.C. in Omaha, Nebraska.
Nominating Committee
Julie Gralow, MD
Dr. Gralow is the director of breast medical oncology at the University of Washington School of Medicine and Fred Hutchinson Cancer Research Center.
Theodore S. Lawrence, MD
Dr. Lawrence is the Isadore Lampe Professor and Chair in the Department of Radiation Oncology at the University of Michigan Medical School. He will serve as the committee chair in 2010-2011.
Read related ASCO Press Release
|
